ELTX earnings: a negative outcome, -9.3%

On March 30, 2022, Elicio Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.3% in the window around the event. It had already run +24.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.